The CCBD consists of type III repeats, each containing ap proximately 90 amino acids (6). Cells bind to the CCBD via receptors of the integrin family (7). Integrins are a(3 het-
erodimeric transmembrane molecules mediating cell-cell adhe sion and attachment of cells to the extracellular matrix (8) .
Integrins that bind the CCBD include a3pi (9), a5fil (10, 11), avj31 (12), av/33 (13), aIIb/33 (14, 15) , and av/36 (16) .
The Arg-Gly-Asp (RGD) sequence in the 10th type III repeat (3Fnl0) is the key attachment site for binding of these inte grals to the CCBD, as demonstrated by inhibition of cell adhe sion with synthetic RGD-containing peptides (17, 18) . Further more, two synergistic regions in the CCBD besides RGD have been identified that are required for cell adhesion through aIIb/33 (19) and a5/31 (20-23). For «5/31 binding to Fn, the synergy region in 3Fn9 is the most important of these two regions (21) , and recently, a short amino acid sequence ProHis-Ser-Arg-Asn (PHSRN) was identified in this repeat that synergistically enhances the cell adhesion promoting activity of the RGD sequence (24) . This sequence is also present in an 11-amino acid integrin binding site from 3Fn9 that is recog nized by allbj33 (25) .
Integrins do not always cons tit utively bind to their ligands with high affinity, Integrin adhesiveness can be stimulated by phorbol esters and other more physiologically relevant agonists (8, 26) . In addition, antibodies have been described to integrin |31 (27-30), j32 (31), and /33 (32) subunits, which induce a high affinity state of the integrins. Studies with stimulatory /31 antibodies on hematopoietic cells have demonstrated modula tion of binding to natural ligands (28-30), modulation of ligand specificity (33), modulation of binding to different regions in one ligand (34) , and modulation of the minimal sequence of a binding site required for adhesion (35) .
In the present study, we have investigated the role of the PHSRN synergy site in «5/31-and av/33-mediated cell adhesion to the CCBD in Fn. We show that requirement for the PHSRN synergy site for cell adhesion to the CCBD depends on the integrins expressed and on the activity of the integrins involved.
MATERIALS AND METHODS
Fibronectin, Fragmentst and Peptides-Plasma Fn was purchased from Sigma. A 120-kDa chymotryptic Fn fragment containing the CCBD (36, 37) was purchased from Life Technologies, Inc. Synthetic peptide Gly-Arg-Gly-Asp-Ser-Pro (GRGDSP) was obtained from the Department of Organic Chemistry, Faculty of Science, University of Nijmegen (The Netherlands) and covalently bound to bovine serum albumin (BSA) as previously described (38) .
Production of Recombinant Fibronectin Polypeptides-To avoid the artifactual losses of adhesive activity known to result from adsorbing short polypeptides on substrates (e g . see Ref. 23 ), we used recombinant Fn polypeptides containing five type III Fn repeats from 3Fn6 through 3FnlO. The 3Fn6-10 wild type expression construct was generated based on the T7 phage promotor and a Fn cDNA fragment encoding Fn type III repeat numbers 6-10 produced using the polymerase chain reaction method (24) ; the PHSRN sequence was present in repeat 9 and RGD in repeat 10 ( Fig. 2A) . The amino-terminal sequence of 3Fn6 starts immediately after an initiation codon for methionine. To create K562  4  4  4  46  7  3  52  3  MV3  4  69  31  62  13  3  107  2  Mel57  3  41  17  23  33  3  33  41 substitution mutants, two complementary oligonucleotides with appro priate sequences were synthesized, annealed, and then cloned between the BarriKI and EcoRl sites of 3Fn9. This yielded a mutated polypeptide 3Fn6-10(SPSDN) where the PHSRN sequence from 3Fn9 was substi tuted by SPSDN from 3Fn8 (Fig, 2, A and B) , Protein expression was induced by 1 mM isopropyl-l-thio-/3-D-galactopyranoside treatment of Escherichia coli strain BL21 (DE3, pLysS) containing the expression plasmid. The expressed recombinant polypeptides were purified by sequential DEAE and hydroxyapatite column chromatography. The polypeptide was eluted from a DEAE column (DE52, Whatman) using a linear gradient of 0-0,5 M NaCl in 10 mM sodium phosphate (pH 7.4), 1 mM EDTA, 0.02% sodium azide, applied to a hydroxyapatite column (Bio-Rad), and eluted using a linear gradient from 5 m M sodium phosphate (pH 6.5), 0.4 mM EDTA, 0.02% sodium azide to 250 mM sodium phosphate (pH 6.5), 0.4 mM EDTA, 0.02% sodium azide. The fractions with peak absorbance were evalu ated for purity by SDS-polyacrylamide gel electrophoresis, pooled, dialyzed against phosphate-buffered saline without Ca2+ or Mg^+ and with 0.02% sodium azide, and stored at -80 °C.
Cell Lines and Culture Conditions -The human melanoma cell lines used included Mel57 (39) and MV3 (40) . The K562 erythroleukemic cell line was provided by Dr. Nancy Hogg. All cell lines were cultured in Dulbecco's modified Eagle's medium (DMEM) (Flow, Irvine, United Kingdom) supplemented with 10% fetal calf serum, penicillin, and streptomycin.
Antibodies-Anti-integrin antibodies included P1B5 anti-a3 (41) Cell Adhesion-Cell adhesion assays were performed as previously described (50) . In short, polystyrene microtiter plates (Greiner, Alphen a/d Rijn, The Netherlands) were coated overnight with the appropriate adhesive ligands and blocked for 1 h at 37 °C with DMEM containing 0.5% (w/v) BSA. Subsequently, 1 X 104 51Cr-labeled cells in 50 jud of DMEM/BSA were added to the wells and incubated for 30 min at 37 °C in 5% C02. Unbound cells were removed by washing with DMEM/BSA, bound cells were lysed by detergent, and radioactivity of the lysate was measured in a gamma counter. Results are presented as the mean percentage of cell binding from triplicate wells. For induction of adhe sion, radiolabeled cells were preincubated with TS2/16 or 8A2 mAbs for 30 min at 4 °C before seeding in the wells or 1 mM MnCl2; or, 100 ng/ml phorbol 12-myristate 13-acetate (PMA) was added to the cells prior to seeding in the wells. For antibody inhibition studies, cells were prein cubated with the appropriate mAbs for 30 min at 4 °C before seeding into the wells.
Flow Cytometry-'Cells were incubated with mAbs in phosphatebuffered saline containing 0.5% (w/v) BSA and 0.02% (w/v) sodium azide for 30 min at 4 °C, After washing with phosphate-buffered saline/ BSA/azide, the cells were incubated with fluoréscein-isothyocyanatelabeled F(ab')2 fragments of rabbit anti-mouse Ig antibodies (Dako, Glostrup, Denmark) for 30 min at 4 °C. After washing, fluorescence was measured on an Epics Elite flow cytometer (Coulter, Mijdrecht, The Netherlands).
Transfection-The full-length cDNA for the integrin /33 subunit (51), a kind gift from Dr. Erkki Ruoslahti, was cloned in the poly linker of the mammalian expression vector pBJlneo (52) B , in 3Fn6-10(SPSDN), 16 amino acid residues from 3Fn9 were sub stituted with the corresponding residues from 3Fn8 to disrupt the PHSRN site in 3Fn9. Boxed sequences are from 3Fn6-10(SPSDN). The region with italicized nucleotides differs from the original sequence in 3Fn8 for technical reasons to alter restriction sites, but this does not alter the amino acid sequence. (Table I ). MV3 and Mel57 expressed «3/31, a4j31, and a5j31. In addition, Mel57 but not MV3 expressed av/33. MV3 and Mel57 expressed other av integrins including avj35 ( 54) and possibly av|31 that may bind to Fn, To exclude influences from domains outside the CCBD that are known to have cell adhesive activity (HepII, IIICS), we used a 120-kDa Fn fragment that lacks the heparin-binding domain and the V region but includes the CCBD. K562 adhered weakly to Fnl20 kDa, whereas MV3 and Mel57 both adhered strongly (Fig. 1) . As expected from the surface expression data, adhesion of K562 was completely blocked by mAbs to a5 or pi. Even though MV3 expressed several Fn-binding integrins, adhesion was fully blocked by mAbs to a5, whereas mAbs to «3 or a4 or polyclonal anti-av had no effect. Adhesion of Mel57 was inhib ited approximately 35% by mAbs to a5 or /31 and about 50% by K562 MV3 Me!57
(ug/ml) (ug/ml) (ug/ml) F ig. 3 . A dhesion to recom binant F n polypeptides. K562, MV3, or Mel57 cells were allowed to adhere to wells coated with increasing concentrations of 3Fn6-10(SPSDN) (dotted line) or 3Fn6-10 {line) as indicated. Adhesion to 0.1 mg/ml BSA was less than 4%. One representative experiment of four is shown.
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MV3-/3 3 16 32 64 32 32 (ug/ml) (ug/ml) Thus, K562 adheres weakly to the CCBD through a5/31, MV3 binds strongly through a5/31, and Mel57 binds strongly through «5/31 and av/33.
K562 and MV3 Require the PH SRN Synergy Site, Whereas for Mel57 RGD Is Sufficient-To study the mechanism of bind ing of these cells to the CCBD, we used a recombinant Fn polypeptide containing 3Fn6-3FnlO and a mutated polypep tide lacking the recently described PHSRN synergy site (24) (Fig. 2) . As shown in Fig. 3, K562 did not adhere to the mutated polypeptide and weakly to the control polypeptide. Only very low adhesion of MV3 cells was observed to the mutated polypeptide, whereas adhesion of MV3 to the control polypep tide was five times higher. In contrast, Mel57 cells adhered strongly to both polypeptides. To investigate if this difference was due to differential expression of av/33, we transfected MV3 cells with j33 cDNA, resulting in av/33 surface expression (Fig.  4A) , and used these cells in adhesion assays. Expression of av/33 provided MV3 cells with the capacity to adhere to GRGDSP (not shown) and to the mutated polypeptide, and this adhesion could be inhibited by C17 anti-/33 mAbs (Fig. 4B) . A similar level of inhibition was found with LM609 anti-av/33 (not shown).
From these results, we conclude that the differential require ment for the PHSRN synergy site for adhesion to RGD in the CCBD of MV3 versus Mel57 is due to the different binding mechanisms of a5/31 versus av/33.
Stimulation of <x5pl-mediated RGB Binding with /3i mAbss PM A, and Manganese-The fact that K562 did not adhere to the mutated polypeptide whereas MV3 did to a low extent (Fig.  3) , even though both cell lines used 0:5)31, suggested that bind ing of «5/31 to RGD in 3FnlO might depend on the activation state of the integrin. To investigate this, we treated both cell lines with 8A2 and TS2/16 stimulatory j31 mAbs, with Mn2+, or with PMA prior to using them in adhesion assays to a GRGDSP peptide. PMA had no effect, 8A2 and TS2/16 induced weak adhesion of K562 to GRGDSP, and treatment of MV3 cells with these mAbs resulted in 25% adhesion to GRGDSP (Fig. 5A) . A control /31-integrin mAb AJ2 had no effect (not shown). The strong binding of Mel57 was not enhanced by 8A2 or TS2/16. Mn2+ was less effective for K562 but induced adhesion of MV3 cells up to 35%. We performed adhesion inhibition assays to examine whether the effect of 8A2 and TS2/16 was due to activation of ct5/31 or to the recruitment of other integrins. Induced adhesion of K562 to GRGDSP in the presence of 8A2 (Fig. 5B) or TS2/16 (not shown) was blocked by mAbs to a5 and not by any of the other mAbs. In addition, even though 8A2 and TS2/16 may activate a3j31, «4/31, «5/31, and possibly av/31 on MV3 cells, induced adhesion of MV3 to GRGDSP was com pletely blocked by mAbs to «5, whereas mAbs to «3, «4, and av had no effect (Fig. 5B) , The fact that the 4B4 anti-jSl mAb did not inhibit adhesion in the presence of 8A2 is in line with the report that activating and inhibiting antibodies share a com mon epitope on the j31 subunit (55).
Thus, the strength of «5/31 binding to RGD can be increased by Mn2'1 ' and by activating /31 antibodies. 
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flo F ig . 5. Stimulation of a501-mediated adhesion to GRGDSP. A, Cells were incubated in the absence (no) or in the presence of PMA, 8A2 or TS2/16 stimulatory /31 mAbs, or manganese (Mn) and allowed to adhere to wells coated with 20 /xg/ml BSA-GRGDSP. B, cells that had been previously incubated in the absence (x) or in the presence of 8A2 stimulatory /31 mAbs (8A2) were incubated in the absence {no) or in the presence of inhibitory anti-integrin mAbs as indicated and allowed to adhere to wells coated with 20 /xg/ml BSA-GRGDSP. Adhesion to BSA was less than 5%. One representative experiment of three is shown. enhanced adhesion to the control polypeptide (Fig. 6) . PMA enhanced adhesion of K562 cells to the control polypeptide but had no effect on adhesion to the mutated polypeptide. For MV3 cells, no effect of PMA was observed, but the low adhesion to the mutated polypeptide was 
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o 1 8 16 32 64 3Fn6-10(SPSDN) (ug/ml) 3F n6-10 (ug/ml) tide. Stimulated adhesion was blocked by the anti-aS mAb and not by any of the other mAbs or their combination (Fig. 7) , suggesting that induction of adhesion to the mutated polypep tide of MV3 by TS2/16 was due to activation of ar5/31 and not to recruitment of other integrins. To investigate possibility 2, we incubated K562 cells with PMA, TS2/16, or Mn2+ and the various combinations and al lowed the cells to adhere to the mutated and control polypep tide. In the presence of the combination of TS2/16 and Mn2+, adhesion to the mutated polypeptide was more than half the level of adhesion to the control polypeptide (Fig. 8) . PMA had no effect by itself on adhesion to the mutated polypeptide but enhanced adhesion to the control polypeptide more than 2-fold. Finally, in the presence of the combination of PMA, TS2/16, and Mn2+, the control and the mutated polypeptide were equally effective in promoting adhesion of K562 cells. This adhesion was blocked by «5 mAbs (not shown).
From these results, we conclude that requirement of the PHSRN synergy site for a5/31-mediated adhesion to RGD in the CCBD depends on the activation state of «5/31.
DISCUSSION
In line with earlier reports, w e find that av/33 does not require the PHSRN site. We base th is conclusion on 2 obser vations. First, Mel57 cells express avf33 and adhere equally well to all molecules tested containing RGD, i.e. GRGDSP, the mutated polypeptide lacking th e synergy site 3 F n 6 -lO(SPSDN), the control polypeptide 3F n6-10, and Fnl20 kDa. Second, the av/33 negative MV3 cells do not adhere to RGDcontaining ligands that lack the P H S R N site, and transfection with j33 cDNA resulting in avj33 surface expression leads to binding of these cells to GRGDSP a n d 3Fn6-10(SPSDN), These findings confirm and ex ten d the observations that av/33 can be retained on an RGD colum n (56) whereas a 5/31 cannot (11). Furthermore, these data are in agreement with the recent report that av-and aS-but n o t <x5-containing integrins are bound by a column containing a Fn fragment lacking the synergy region (57). Similarly, it h a s been reported that <*IIb/33 but not av/33 binding to Fn can be inhibited by an 11-amino acid peptide from 3Fn9 that also contains the PHSRN sequence (25). Thus, RGD is sufficient for binding to Fn through avfi3, RGD through a5/31. Alterna  tively, as previously reported (63), stimulatory j81 mAbs may  selectively activate a5/31 while leaving a4/31 unaffected. A possible interpretation of our findings may be that the PHSRN synergy site binds to the same epitope as recognized by the stimulatory p i mAbs. It has been previously suggested that the epitope where these mAbs bind may physically interact with extracellular proteins (55). However, the fact that binding of K562 to 3Fn6-10 can be enhanced in the presence of 8A2 or TS2/16 when PMA is absent indicates that the synergy site and stimulatory mAbs can have additional combined stimulatory effects. Therefore, these data seem to support a model where the synergy site and stimulatory mAbs have different binding sites on a5/31. This is in agreement with the recent report that the mechanism of binding of integrin a5/31 to Fn seems to be through binding of the a5 subunit to the synergystic regions and of the /31 subunit to RGD (64),
In conclusion, our data demonstrate that a5/31 but not avj33 requires the PHSRN synergy site for cell adhesion to RGD in the CCBD of Fn but that induction of a high affinity state of a5/31 with PMA, stimulatory mAbs, and/or Mn2+ abrogates this dependence on the PHSRN sequence.
